Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.14
-0.55 (-7.15%)
At close: Oct 2, 2026, 4:00 PM EDT
7.14
0.00 (0.00%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $471.6 million as of October 2, 2026. Its market cap has increased by 18.55% in one year.
Market Cap
471.60M
Enterprise Value
591.23M
1-Year Change
18.55%
Ranking
Category
Stock Price
$7.14
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $471.60M, an increase of 73.83%. That is a compound annual growth rate of 6.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 471.60M | 9.39% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Collegium Pharmaceutical | 723.71M |
| Ironwood Pharmaceuticals | 687.40M |
| Glass House Brands | 639.91M |
| Evotec SE | 594.18M |
| Aquestive Therapeutics | 586.14M |
| Tilray Brands | 541.12M |
| Kamada | 498.65M |
| Alpha Teknova | 487.49M |